Local companies get post-Pfizer dollars
Four Ann Arbor companies are among the first to receive low-interest loans through a state program geared at retaining Pfizer Pharmaceutical, Inc., talent and assets.
Biotechnology
Latest in Biotechnology
U of M docs to perform state-of-the-art surgery online
Minimally invasive procedure is safer for many patients. Not convinced? Why not check it out onlive... live!
Massachusetts investment firm bankrolls Michigan biotech
A Massachusetts investment group has poured more than a million dollars into Michigan biotech firms in the past two years.
State plan geared toward retaining former Pfizer assets
The state's Strategic Fund Board has approved an $8 million loan program that should enable local life sciences businesses to purchase Pfizer assets.
Ann Arbor Compendia lands $2.5M plus, to add 10-15 positions
Compendia Bioscience, Inc., an Ann Arbor-area biotech company has gotten a $250,000 investment from Ann Arbor SPARK and a $2.4 million research grant from the National Cancer Institute.
New start-up firms to occupy old Ann Arbor Pfizer space
With the help of Ann Arbor SPARK, new companies and University of Michigan researchers are starting to move into the former Pfizer wet lab section.
In Pfizer’s Wake
Pfizer walks out the door and opportunity comes in through the window. Ann Arbor takes inspiration from another Michigan community's post-Pfizer successes and seeds the ground with start ups, SPARK and state support.
Good Things Come In Small Packages
Since the decline of the Big Three, it's become clear Michigan businesses need a new model. As technology firms pop up, and global communications allow small companies to compete internationally like never before, more start-ups are realizing that it pays to be David when you're battling Goliaths.
Video Xoran Technologies
Xoran Technologies is on a mission to cut healthcare costs through efficiency and innovation. It's been a winning strategy for both the company and Ann Arbor's growing life sciences industry
U of M docs to perform state-of-the-art surgery online
Minimally invasive procedure is safer for many patients. Not convinced? Why not check it out onlive... live!
Massachusetts investment firm bankrolls Michigan biotech
A Massachusetts investment group has poured more than a million dollars into Michigan biotech firms in the past two years.
State plan geared toward retaining former Pfizer assets
The state's Strategic Fund Board has approved an $8 million loan program that should enable local life sciences businesses to purchase Pfizer assets.
Ann Arbor Compendia lands $2.5M plus, to add 10-15 positions
Compendia Bioscience, Inc., an Ann Arbor-area biotech company has gotten a $250,000 investment from Ann Arbor SPARK and a $2.4 million research grant from the National Cancer Institute.
New start-up firms to occupy old Ann Arbor Pfizer space
With the help of Ann Arbor SPARK, new companies and University of Michigan researchers are starting to move into the former Pfizer wet lab section.
In Pfizer’s Wake
Pfizer walks out the door and opportunity comes in through the window. Ann Arbor takes inspiration from another Michigan community's post-Pfizer successes and seeds the ground with start ups, SPARK and state support.
Good Things Come In Small Packages
Since the decline of the Big Three, it's become clear Michigan businesses need a new model. As technology firms pop up, and global communications allow small companies to compete internationally like never before, more start-ups are realizing that it pays to be David when you're battling Goliaths.
Video Xoran Technologies
Xoran Technologies is on a mission to cut healthcare costs through efficiency and innovation. It's been a winning strategy for both the company and Ann Arbor's growing life sciences industry
